The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

Staking their claim

If you think the current political scene is divisive, just try mentioning soy to a group of natural health practitioners. And then stand back and give them some swinging room. You might also want to wear a safety helmet.

For many years, the questions about soy’s benefits and drawbacks have raised passionate debates. And those debates intensified recently when The Solae Company (a soy protein producer) submitted a petition to the FDA, requesting that manufacturers of soy products be allowed to claim that soy consumption may reduce the risk of certain types of cancer.

That’s a pretty tall claim. And some are saying that there’s no merit to it. But others go even further, claiming that soy intake may actually increase cancer risk.

Battleground states have got nothing on this face off.

Interested party

In a press release about the FDA petition, The Solae Company describes itself as “a leader in the research of soy protein.” And it’s true; Solae does research soy protein. In fact, Solae researchers spent three years conducting an analysis of 58 studies they say supports the claim that soy protein-based foods reduce the risk of breast, prostate and colon cancer.

But Solae isn’t exactly a modest little mom’n’pop operation just trying to make a go of it in a competitive marketplace. And when it comes to research, the folks at Solae certainly don’t represent a disinterested party. Solae is one of the world’s largest soy producers, co-owned by Bunge Limited (an international agribusiness giant), and DuPont. In other words, they’re big. And they’re playing for keeps. And if the FDA allows them to make the claim that soy helps prevent cancer, just imagine what that could do for soy products sales.

Solae executives have imagined that very thing, and by their own estimate soy profits could easily double if the FDA gives a green light to the cancer claim.

The proof is in the processing

By and large, soy has a reputation as a health food. But that reputation has been changing over the past few years.

In the e-Alert “Adult Swim” (4/16/03), HSI Panelist Allan Spreen, M.D., expressed his doubts about soy, saying, “When you take the basic components of the soybean, and then add to that the modern procedures of cultivation and mass production, you have a highly processed food of dubious nutritional value.”

But Dr. Spreen’s soy reservations are mild compared to those of Kaayla T. Daniel, Ph.D., author of the book “The Whole Soy Story” (scheduled for publication later this year). Dr. Daniel states that soy protein may actually help cause and accelerate cancer growth. About Solae’s FDA petition, the Weston A. Price Foundation (WAPF) quotes Dr. Daniel in a press release: “Solae was highly selective in its choice of evidence and biased in its interpretations. It omitted many studies that show soy to be ineffective in preventing cancer, emphasized favorable outcome in studies when results were mixed and excused results of a few unfavorable studies”

Formula for disaster

It’s not surprising that the Weston A. Price Foundation would weigh in on this topic. Sally Fallon and Mary G. Enig, Ph.D., of the WAPF have been two of the most outspoken critics of soy for many years. (It should be noted that WAPF – a nutrition education and research group – is pro-raw dairy.)

On the WAPF web site (westonaprice.org) I found a page containing the abstracts of 56 studies conducted between 1971 and 2003, which serve as something of a rebuttal to Solae’s analysis of 58 studies. (That page is not designed to be an actual rebuttal; the WAPF list was originally compiled two years ago.) Among the conclusions of the 56 studies: Soy protein intake was significantly associated with elevated stomach cancer mortality rate in men, and colorectal cancer mortality rates in both sexes. Soy products have also been shown to depress thyroid function, which may prompt cancer of the thyroid.

But what’s arguably even more worrying than the cancer outcomes are the studies that show numerous health hazards linked to the consumption of soy-based baby formula. For instance, a normal daily intake of soy formula delivers the same amount of estrogen contained in five birth control pills. The result: an alarming number of girls under the age of ten are showing signs of puberty, while male infants experience testosterone levels as high as those of an adult male.

A bit of a stretch

There’s a good chance that Solae executives don’t really expect the FDA to allow them to make their reduced cancer risk claims. Just by petitioning the FDA they’ve given a higher profile to their analysis of 58 studies, while planting the idea that soy may be a cancer preventive. And if the FDA denies their petition, no harm done – the soy industry can still say that the FDA has reviewed 58 studies that support the cancer claim.

The FDA is expected to respond to the petition before the end of the year, and I’ll keep you posted on the outcome. Until then, I’ll leave you with this note from Dr. Jonathan Wright, M.D., who advises his patients and readers to restrict their soy consumption to no more than three servings per week until the soy debate is better resolved.

Sources:
“FDA Reviews Health Claim Petition Regarding Reduction in Cancer Risk” The Solae Company, Press Release, PR Newswire, 4/16/04, findarticles.com
“Health Experts Urge FDA To Deny Soy Protein Cancer Prevention Health Claim” Weston A. Price Foundation, Press Release, 7/5/04, westonaprice.org
“Studies Showing Adverse Effects of Dietary Soy, 1971-2003″ Weston A. Price Foundation” westonaprice.org

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.